{"id":3529,"date":"2020-04-22T14:42:57","date_gmt":"2020-04-22T18:42:57","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/"},"modified":"2026-07-15T15:57:31","modified_gmt":"2026-07-15T19:57:31","slug":"2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/","title":{"rendered":"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19"},"content":{"rendered":"\nGenSight sera pr\u00e9sent \u00e0 la conf\u00e9rence <a href=\"https:\/\/www.aan.com\/conferences-community\/annual-meeting\/\" target=\"_blank\" rel=\"noopener\"><strong>American Academy of Neurology<\/strong><\/a> (AAN) Annual Meeting, programm\u00e9e du 25 avril au 1<sup>er<\/sup> mai \u00e0 Toronto au Canada.\n\nUne pr\u00e9sentation orale scientifique a \u00e9t\u00e9 accept\u00e9e dans le programme de la conf\u00e9rence.\n\nTitre\u00a0: <em>rAAV2\/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): Final Results from the RESCUE and REVERSE Phase III Clinical Trials and Experimental Data in Nonhuman Primates to Support a Bilateral Effect<\/em>\n<ul>\n \t<li>Pr\u00e9sentateur : <strong> Mark L. Moster, MD<\/strong>, Neuro-Ophthalmology, Wills Eye Hospital and Professor of Neurology and Ophthalmology at Thomas Jefferson University, Philadelphia, PA, USA ; Principal Investigator in the REVERSE, RESCUE, and REFLECT trials<\/li>\n \t<li><em>Session : S32 &#8211; Neuro-ophthalmology\/Neuro-otology <\/em><\/li>\n \t<li><em>Sujet : Neuro-ophthalmology\/Neuro-otology <\/em><\/li>\n \t<li><em>Programme : S32.005 <\/em><\/li>\n<\/ul>\nPlus de d\u00e9tails \u00a0: <a href=\"https:\/\/bit.ly\/2xjiWo8\" target=\"_blank\" rel=\"noopener\">https:\/\/bit.ly\/2xjiWo8<\/a>\n","protected":false},"excerpt":{"rendered":"<p>GenSight sera pr\u00e9sent \u00e0 la conf\u00e9rence American Academy of Neurology (AAN) Annual Meeting, programm\u00e9e du 25 avril au 1er mai \u00e0 Toronto au Canada. Une pr\u00e9sentation orale scientifique a \u00e9t\u00e9 accept\u00e9e dans le programme de la conf\u00e9rence. Titre\u00a0: rAAV2\/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): Final Results from the RESCUE and REVERSE [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[55],"tags":[],"featured-area":[],"news-topic":[73],"news-type":[74,75,77],"post-year":[],"class_list":["post-3529","post","type-post","status-publish","format-standard","hentry","category-evenements","news-topic-gs010-lumevoq","news-type-product-candidates","news-type-clinical","news-type-conferences"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19 - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19 - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"GenSight sera pr\u00e9sent \u00e0 la conf\u00e9rence American Academy of Neurology (AAN) Annual Meeting, programm\u00e9e du 25 avril au 1er mai \u00e0 Toronto au Canada. Une pr\u00e9sentation orale scientifique a \u00e9t\u00e9 accept\u00e9e dans le programme de la conf\u00e9rence. Titre\u00a0: rAAV2\/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): Final Results from the RESCUE and REVERSE [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-22T18:42:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-15T19:57:31+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/04\\\/22\\\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/04\\\/22\\\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19\",\"datePublished\":\"2020-04-22T18:42:57+00:00\",\"dateModified\":\"2026-07-15T19:57:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/04\\\/22\\\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\\\/\"},\"wordCount\":133,\"articleSection\":[\"Evenements\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/04\\\/22\\\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/04\\\/22\\\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\\\/\",\"name\":\"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19 - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-04-22T18:42:57+00:00\",\"dateModified\":\"2026-07-15T19:57:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/04\\\/22\\\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/04\\\/22\\\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/04\\\/22\\\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19 - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/","og_locale":"fr_FR","og_type":"article","og_title":"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19 - GenSight Biologics","og_description":"GenSight sera pr\u00e9sent \u00e0 la conf\u00e9rence American Academy of Neurology (AAN) Annual Meeting, programm\u00e9e du 25 avril au 1er mai \u00e0 Toronto au Canada. Une pr\u00e9sentation orale scientifique a \u00e9t\u00e9 accept\u00e9e dans le programme de la conf\u00e9rence. Titre\u00a0: rAAV2\/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): Final Results from the RESCUE and REVERSE [&hellip;]","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/","og_site_name":"GenSight Biologics","article_published_time":"2020-04-22T18:42:57+00:00","article_modified_time":"2026-07-15T19:57:31+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19","datePublished":"2020-04-22T18:42:57+00:00","dateModified":"2026-07-15T19:57:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/"},"wordCount":133,"articleSection":["Evenements"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/","name":"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19 - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2020-04-22T18:42:57+00:00","dateModified":"2026-07-15T19:57:31+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/04\/22\/2020-aan-annual-meeting-toronto-canada-annule-a-cause-du-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"2020 AAN Annual Meeting, Toronto, Canada \u2013 annul\u00e9 \u00e0 cause du COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/3529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=3529"}],"version-history":[{"count":0,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/3529\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=3529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=3529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=3529"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=3529"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=3529"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=3529"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=3529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}